C21 Investments Inc. (CSE:CXXI)

Market Cap	55.35M
Revenue (ttm)	43.75M
Net Income (ttm)	-4.52M
Shares Out	117.77M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,000
Average Volume	54,858
Open	0.4750
Previous Close	0.4700
Day's Range	0.4500 - 0.4850
52-Week Range	0.1500 - 0.6800
Beta	2.83
RSI	52.31
Earnings Date	Nov 14, 2025

About C21 Investments

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 138
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CXXI

Financial Performance

In 2024, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million. Losses were -$3.97 million, 789.2% more than in 2023.

Financial numbers in USD